Compare COFS & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COFS | CTKB |
|---|---|---|
| Founded | 1898 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.9M | 541.1M |
| IPO Year | 1995 | 2021 |
| Metric | COFS | CTKB |
|---|---|---|
| Price | $33.89 | $4.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $34.00 | $5.63 |
| AVG Volume (30 Days) | 75.3K | ★ 774.0K |
| Earning Date | 04-24-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.74 | N/A |
| Revenue | ★ $227,624,000.00 | $193,015,000.00 |
| Revenue This Year | $22.13 | $5.42 |
| Revenue Next Year | $4.47 | $7.03 |
| P/E Ratio | $19.56 | ★ N/A |
| Revenue Growth | ★ 63.64 | 17.67 |
| 52 Week Low | $26.10 | $3.28 |
| 52 Week High | $35.00 | $6.18 |
| Indicator | COFS | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 48.20 | 60.88 |
| Support Level | $33.57 | $4.15 |
| Resistance Level | $34.91 | $5.24 |
| Average True Range (ATR) | 0.65 | 0.23 |
| MACD | -0.09 | 0.04 |
| Stochastic Oscillator | 26.74 | 85.96 |
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.